Kuano

Founded: 2020 • Age: 6 yrs
AI and quantum services for molecular design are provided.
Request Access

About Kuano

Kuano is a company founded in 2020 by David Wright. It operates as a AI-as-a-Service. Kuano has raised $3.63 million across 2 funding rounds from investors including Mercia, ACF Investors and Ascension Ventures. The company has 4 employees as of March 31, 2022. Kuano offers products and services including Quantum Simulation & AI Solutions. Kuano operates in a competitive market with competitors including Owkin, Formation Bio, AbSci, BigHat and Predictive Oncology, among others.

  • Employees 4 as on 31 Mar, 2022
  • Founders David Wright
  • Sectors
    Healthcare
    Technology
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Kuano Ltd.
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Technology → Quantum & Emerging Technologies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $3.63 M (USD)

    in 2 rounds

  • Latest Funding Round
    $2.25 M (USD), Seed

    Sep 12, 2023

  • Investors
    Mercia

    & 4 more

  • Employee Count
    4

    as on Mar 31, 2022

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Kuano

Kuano offers a comprehensive portfolio of products and services, including Quantum Simulation & AI Solutions. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Solutions for drug design using quantum and AI technology.

People of Kuano
Headcount 10-50
Employee Profiles 6
Board Members and Advisors 9
Employee Profiles
People
Vid Stojevic
CEO
People
David Wright
CTO & Co-founder
People
Will Gerrard
Computational Drug Design & ML Scientist
People
Jarryl D'Oyley
Project Manager And Co-founder

Unlock access to complete

Board Members and Advisors
people
Antonio Benedetti
Chairman
people
Alessandra Cesano
Advisor
people
Adrian Mulholland
Advisor
people
Andrew Green
Advisor

Unlock access to complete

Funding Insights of Kuano

Kuano has successfully raised a total of $3.63M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $2.25 million completed in September 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Seed — $2.3M
  • First Round

    (08 Jul 2021)

  • Investors Count 5
Date Amount Transaction Name Valuation Lead Investors Investors
Sep, 2023 Amount Seed - Kuano Valuation Mercia
Jul, 2021 Amount Seed - Kuano Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Kuano

Kuano has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Mercia, ACF Investors and Ascension Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Venture capital firm focused on angel investments
Founded Year Domain Location
Strategic investments in healthcare technologies and data innovations.
Founded Year Domain Location
Investment management services are provided by Mercia to various clients.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Kuano

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Kuano

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Kuano Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Kuano

Kuano operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Owkin, Formation Bio, AbSci, BigHat and Predictive Oncology, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
An agentic AI platform is developed for biomedical research insights.
domain founded_year HQ Location
AI-powered drug discovery platform for various diseases
domain founded_year HQ Location
AI-based technology is used for recombinant protein production in therapeutics.
domain founded_year HQ Location
Antibody therapies are developed through machine learning and synthetic biology.
domain founded_year HQ Location
AI-based platform for cancer diagnostics and precision medicine is utilized.
domain founded_year HQ Location
AI platform used for extracting antibody data from scientific papers.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Kuano

Frequently Asked Questions about Kuano

When was Kuano founded?

Kuano was founded in 2020 and raised its 1st funding round 1 year after it was founded.

Is Kuano a funded company?

Kuano is a funded company, having raised a total of $3.63M across 2 funding rounds to date. The company's 1st funding round was a Seed of $1.38M, raised on Jul 08, 2021.

How many employees does Kuano have?

As of Mar 31, 2022, the latest employee count at Kuano is 4.

What does Kuano do?

Kuano is engaged in developing quantum simulation and AI-driven solutions for drug design. The company operates in the biotechnology and pharmaceutical sectors, leveraging advanced technology to enhance drug discovery processes. Their expertise lies in combining quantum computation with artificial intelligence to address complex challenges in enzyme inhibition and drug development.

Who are the top competitors of Kuano?

Kuano's top competitors include Owkin, Formation Bio and XtalPi.

What products or services does Kuano offer?

Kuano offers Quantum Simulation & AI Solutions.

Who are Kuano's investors?

Kuano has 5 investors. Key investors include Mercia, ACF Investors, Ascension Ventures, o2h ventures, and Meltwind Advisory.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available